The endothelin system and its potential as a therapeutic target in cardiovascular disease

Pharmacology and Therapeutics

Volumn 72, Issue 2, 1996, Pages 109-148

  Gray, Gillian A ^a   Webb, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

chronic heart failure; endothelin converting enzyme; endothelin genes; endothelin receptor antagonists; endothelin receptor genes; hypertension

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR AGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHORAMIDON;

ANIMAL EXPERIMENT; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CHRONOTROPISM; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE CELL; HUMAN; INOTROPISM; NONHUMAN; PATHOPHYSIOLOGY; PRESSOR RESPONSE; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; VASOCONSTRICTION;

AMINO ACID SEQUENCE; ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGY; ENDOTHELIN-1; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, ENDOTHELIN;

EID: 0030444643     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(96)00101-5     Document Type: Review

References (453)

1. Adachi, M., Yang, Y-Y., Furuichi, Y. and Watanabe, T. (1991) Cloning and characterization of cDNA encoding human A-type endothelin receptor. Biochem. Biophys. Res. Commun., 180: 1265-1272.
2. Adachi, M., Hashido, K., Trzeciak, A., Watanabe, T., Furuichi, Y. and Miyamoto, C. (1993) Functional domains of human endothelin receptor. J. Cardiovasc. Pharmacol. 22: S121-S124.
3. Adachi, M., Furuichi, Y. and Miyamoto, C. (1994) Identification of a ligand binding site of the human endothelin-A receptor and specific regions required for ligand selectivity. Eur. J. Biochem. 220: 37-43.
4. Alafaci, C., Jansen, I., Arbab, M. A., Shiokawa, Y., Svendgaard, N. A. and Edvinsson, L. (1990) Enhanced vasoconstrictor effect of endothelin in cerebral arteries from rats with subarachnoid haemorrhage. Acta Physiol. Scand. 138: 317-319.
5. Andrawis, N. S., Gilligan, J. and Abernethy, D. R. (1992) Endothelin-1-mediated vasoconstriction: specific blockade by verapamil. Clin. Pharmacol. Ther. 52: 583-589.
6. Anggård, E., Galton, S. and Rae, G. (1989) The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S46-S49.
7. Arai, H., Hori, S., Aramori, I., Ohkubo, H. and Nakamichi, S. (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732.
8. Arai, H., Nakao, K., Takaya, K., Hosoda, K., Ogawa, Y., Nakanishi, S. and Imura, H. (1993) The human endothelin B receptor gene. Structural organization and chromosomal assignment. J. Biol. Chem. 268: 3463-3470.
9. Arai, M., Yoguchi, A., Iso, T., Takahashi, T., Imai, S., Murata, K. and Suzuki, T. (1995) Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. Am. J. Physiol. 268: H2084-H2091.
10. Aramori, I., Nirei, H., Shoubo, M., Sogabe, K., Nakamura, K., Kojo, H., Notsu, Y., Ono, T. and Nakanishi, S. (1993) Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells. Mol. Pharmacol. 40: 127-131.
11. Artigou, J. Y., Salloum, J., Carayoni, A., Lechat, P. H., Maistre, G., Isnard, R., Komajda, M., Legrand, J. C. and Grosgogeat, Y. (1993) Variations in plasma endothelin concentrations during coronary spasm. Eur. Heart J. 14: 780-784.
12. Asano, T., Ikegaki, I., Suzuki, Y., Satoh, S. and Shibuya, M. (1989) Endothelin and the production of cerebral vasospasm in dogs. Biochem. Biophys. Res. Commun. 159: 1345-1351.
13. Asano, T., Ikegaki, I., Satoh, S., Suzuki, Y., Shibuya, M., Sugita, K. and Hidaka, H. (1990) Endothelin: a potential modulator of cerebral spasm, Eur. J. Pharmacol. 190: 365-372.
14. Auguet, M., Delaflotte, S., Chabrier, P. E. and Braquet, P. (1992) The vasoconstrictor action of big endothelin-1 is phosphoramidon-sensitive in rabbit saphenous artery, but not in saphenous vein. Eur. J. Pharmacol. 224: 101-102.
15. Azuma, H., Hamasaki, H., Nümi, Y., Terada, T. and Matsubara, O. (1994) Role of endothelin-1 in neointima formation after endothelial removal in rabbit carotid arteries. Am. J. Physiol. 267: H2259-H2267.
16. Balwierczak, J. L., Kukkola, P. J., Savage, P. and Jeng, A. Y. (1995) Effects of metalloprotease inhibitors on smooth muscle endothelin-converting enzyme activity. Biochem. Pharmacol. 49: 291-296.
17. Barnes, K., Murphy, L. J., Takahashi, M., Tanzawa, K. and Turner, A. J. (1995) Localisation and biochemical characterisation of endothelin-converting enzyme. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S37-S39.
18. Barone, F. C., White, R. F., Elliot, J. D., Feuerstein, G. Z. and Ohlstein, E. H. (1995) The endothelin receptor antagonist SB217242 reduces cerebral focal ischaemic brain injury. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S404-S407.
19. B receptors on aortic smooth muscle cells of spontaneously hypertensive rats. Am. J. Physiol. 264: C479-C484.
20. Bax, W. A. and Saxena, P. R. (1994) The current endothelin receptor classification: time for reconsideration? Trends Pharmacol. Sci. 15: 379-386.
21. A) receptor antagonist in conscious rats. J. Cardiovasc. Pharmacol. 20: 940-948.
22. Bedarida, G. V., Kim, D., Blaschke, T. F. and Hoffman, B. B. (1993) Venodilatation in Raynaud's disease. Lancet 342: 1451-1454.
23. Belch, J. J. F. (1991) Raynaud's phenomenon. Curr. Opin. Rheumatol. 3: 960-966.
24. Benatti, L., Bonecchi, L., Cozzi, L. and Sarmientos, P. (1993) Two prepro endothelin mRNAs transcribed by alternative promoters. J. Clin. Invest. 91: 1149-1156.
25. Benatti, L., Fabbrini, M. S. and Patrono, C. (1994) Regulation of ET-1 biosynthesis. Ann. NY Acad. Sci. 714: 109-121.
26. B-receptor-mediated effects of endothelin-1 and (Ala1, 3,11,15)endothelin-1 by BQ-123 in the anaesthetized rat. Br. J. Pharmacol. 107: 912-918.
27. Bihovsky, R., Levinson, B. L., Loewi, R. C., Erhardt, P. W. and Polokoff, M. A. (1995) Hydroxamic acids as potent inhibitors of endothelin-converting enzyme from human bronchiolar smooth muscle. J. Med. Chem. 38: 2119-2129.
28. Bloch, K. D., Eddy, R. L., Shows, T. B. and Quertetmous, T. (1989a) cDNA cloning and chromosomal assignment of the gene encoding endothelin 3. J. Biol. Chem. 264: 18156-18161.
29. Bloch, K. D., Freidrich, S. P., Lee, M-E., Eddy, R. L., Shows, T. B. and Quertermous, T. (1989b) Structural organisation and chromosomal assignment of the gene encoding endothelin. J. Biol. Chem. 264: 10851-10857.
30. Bloch, K. D., Hong, C. C., Eddy, R. L., Shows, T. B. and Quertermous, T. (1991) cDNA cloning and chromosomal assignment of the endothelin 2 gene: vasoactive intestinal contractor peptide is rat endothelin 2. Genomics 10: 236-242.
31. Boarder, M. R. and Marriott, D. B. (1989) Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromaffin cells. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S223-S224.
32. 125I]-endothelin-1 binding sites in human umbilical artery. Eur. J. Pharmacol. 249: 299-305.
33. Boulanger, C. and Lüscher, T. F. (1990) Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85: 587-590.
34. Boulanger, C. M., Tanner, F. C., Bea, M. L. Hahn, A. W., Werner, A. and Lüscher, T. F. (1992) Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ. Res. 70: 1191-1197.
35. Brändli, P., Löffler, B-M., Breu, V., Osterwalder, R., Maire, J-P. and Clozel, M. (1996) Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater. Pain 64: 315-322.
36. Braquet, P., Touvay, C., Lagente, V., Vilain, B., Pons, F., Hosford, D., Chabrier, P. E. and Mencia-Huerta, J. M. (1989) Effect of endothelin-1 on blood pressure and bronchopulmonary system of the guinea pig. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S143-S146.
37. Brooks, D. P., DePalma, P. D., Pullen, M. and Nambi, P. (1994) Characterization of canine renal endothelin receptor subtypes and their function. J. Pharmacol. Exp. Ther. 268: 1091-1097.
38. Burbach, J. P. H. and Meijer, O. C. (1992) The structure of neuropeptide receptors. Eur. J. Pharmacol. Mol. Pharmacol. 227: 1-18.
39. Cade, C., Lumma, W. C., Mohan, R., Rubanyi, G. M. and Parker-Botelho, L. H. (1990) Lack of biological activity of prepro endothelin (110-130) in several endothelin assays. Life Sci. 47: 2097-2103.
40. Caldwell, P. R. B., Seegal, B. C., Hsu, K. C., Das, M. and Soffler, R. L. (1976) Angiotensin-converting enzyme: vascular endothelial localization. Science 191: 1050-1051.
41. Cambien, F., Costerousse, O., Tiret, L., Poirier, O., Lecerf, L., Gonzales, M. F., Evans, A., Arveiler, D., Cambou, J. P., Luc, G., Rakotovao, R., Ducimetre, P., Soubrier, F. and Alhenc-Gelas, F. (1994) Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90: 669-676.
42. Cao, L. and Banks, R. O. (1990a) Cardiorenal actions of endothelin, part I: effects of converting enzyme inhibition. Life Sci. 46: 577-583.
43. Cao, L. and Banks, R. O. (1990b) Cardiorenal actions of endothelin, part II: effects of cyclooxygenase inhibitors. Lite Sci. 46: 585-590.
44. Cavero, P. G., Miller, W. L., Heuhlein, D. M., Margulies, K. B. and Burnett, J. C. (1990) Endothelin in experimental heart failure in the anaesthetized dog. Am. J. Physiol. 259; F312-F317.
45. Cicila, G. T., Rapp, J. P., Bloch, K. D., Kurtz, B. E., Pravenec, M., Kren, V., Hong, C. C., Quertermous, T. and Ng, S. C. (1994) Cosegregation of the endothelin-3 locus with blood pressure and relative heart weight in inbred Dahl rats. J. Hypertens, 12: 643-651.
46. A receptor antagonist. J. Cardiovasc. Pharmacol. 24: 587-594.
47. 22]-big endothelin-1 [19-37]: anew and potent inhibitor of the endothelin-converting enzyme. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S72-S74.
48. Clarke, J. G. Benjamin, N., Larkin, S. W., Webb, D. J., Keogh, B. E., Davies, G. J. and Maseri, A. (1989a) Endothelin is a potent long-lasting vasoconstrictor in man. Am. J. Physiol. 257: H2003-H2035.
49. Clarke, J. G., Larkin, S. W., Benjamin, N., Keogh, B. E., Chester, A., Davies, G. J., Taylor, K. M. and Maseric, A. (1989b) Endothelin-1 is a potent long-lasting vasoconstrictor in dog peripheral vasculature in vivo. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S211-S212.
50. Clozel, M. (1989) Endothelin sensitivity and receptor binding in the aorta of spontaneously hypertensive rats. J. Hypertens. 7: 913-917.
51. Clozel, M. and Clozel, J. P. (1989) Effects of endothelin on regional blood flows in squirrel monkeys. J. Pharmacol. Exp. Ther. 250: 1125-1131.
52. Clozel, M. and Fischli, W. (1989) Human cultured endothelial cells do secrete endothelin-1. J. Cardiovasc. Pharmacol. 13: S229-S231.
53. A antagonist, prevents the early cerebral vasospasm following subarachnoid haemorrhage after intracisternal but not intravenous injection. Life Sci. 52: 825-832.
54. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem. Biophys. Res. Commun. 186: 867-873.
55. Clozel, M., Breu, V., Burri, K., Cassal, J., Fischli, W., Gray, G. A., Hirth, G., Löffler, B. M., Müller, M., Neidhart, W. and Ramuz, H. (1993) Pathophysiological role of endothelin as revealed by the first orally active endothelin receptor antagonist. Nature 365: 759-761.
56. Clozel, M., Breu, V., Gray, G. A., Kalina, B., Löffler, B. M., Burri, K., Cassal, J. M., Hirth, G., Müller, M., Neidhart, W. and Ramuz, H. (1994) Pharmacological characterization of bosentan, a new orally active non-peptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270: 228-235.
57. Cockcroft, J. R., Clarke, J. G. and Webb, D. J. (1991) The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man. Br. J. Clin. Pharmacol. 31: 521-524.
58. B receptor antagonist (PD 145065) and related analogues, Med. Chem. Res. 3: 154-162.
59. Cody, W. L., Doherty, A. M., He, J. X., De Pue, P. L., Rapundalo, S., Hingorani, G. A., Major, T. C., Panek, R. L., Dudley, D. T., Haleen, S. J., La Douceur, D., Hill, K. E., Flynn, M. A. and Reynolds, E. E. (1992) Design of a functional hexapeptide antagonist of endothelin (1). J. Med. Chem. 35: 3301-3303.
60. Cohn, J. N., Johnson, G., Zeische S., Cobb, F., Francis, G., Tristan, F., Smith, R., Dunkman, B., Loeb, H., Wong, M., Bhat, G., Goldmans, S., Fletcher, R. D., Doherty, J., Hughes, V., Carson, P., Cintron, G. S., Habetai, R. and Haakenson, C. (1991) A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N. Engl. J. Med. 325: 303-310.
61. Cooke, E. D. and Nicolaides, A. N. (1990) Raynaud's syndrome. Br. Med. J. 300: 553-555.
62. Cotton, L. T. and Khan, O. (1986) Raynaud's phenomenon: a review. Int. Angiol. 5: 215-236.
63. Cozza, E. N., Gomez-Sanchez, C. E., Foecking, M. and Chiou, S. (1989) Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J. Clin. Invest. 84: 1032-1035.
64. Criscione, L., Nellis, P., Riniker, B., Thomann, H. and Burdet, R. (1990) Reactivity and sensitivity of mesenteric vascular beds and aortic rings of spontaneously hypertensive rats to endothelin: effects of calcium entry blockers. Br. J. Pharmacol. 100: 31-36.
65. Cristol, J. P., Warner, T. D., Thiemermann, C. and Vane, J. R. (1993) Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br. J. Pharmacol. 108: 776-779.
66. Curran, T. and Franza, B. (1988) Fos and Jun: the AP-1 connection. Cell 55: 395-397.
67. A receptors in humans? Trends Pharmacol. Sci. 15: 9-11.
68. Davenport, A. P., Ashby, M. J., Easton, P., Ella, S., Bedford, J., Dickerson, C., Nunez, D. J., Capper, S. J. and Brown, M. J. (1990) A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin. Sci. 78: 261-264.
69. B receptors in human vascular smooth muscle. J. Cardiovasc. Pharmacol. 22: S22-S25.
70. Deleuze, P. H., Adnot, S., Shiiya, N., Thorval, F. R., Eddahibi, S., Braquet, P., Chabrier, P. E. and Loisance, D. Y. (1992) Endothelin dilates bovine pulmonary circulation and reverses hypoxic pulmonary vasoconstriction. J. Cardiovasc. Pharmacol. 19: 354-360.
71. De Lombaert, S., Ghai, R. D., Jeng, A. Y., Trapani, A. J. and Webb, R. L. (1994) Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem. Biophys. Res. Commun. 204: 407-412.
72. Deng, A. Y., Savage, P., Shetty, S. S., Martin, L. L. and Jeng, A. Y. (1992) Identification and partial purification of a thiol endothelin-converting enzyme from porcine aortic endothelial cells. J. Biochem. (Tokyo) 111: 346-351.
73. Deng, A. Y., Martin, L. L., Balwierczak, J. L. and Jeng, A. Y. (1994) Purification and characterization of an endothelin degradation enzyme from rat kidney. J. Biochem. 115: 120-125.
74. Deng, L. Y. and Schiffrin, E. L. (1992) Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am. J. Physiol. 262: H1782-H1787.
75. Deng, L-Y., Li, J-S. and Schiffrin, E. L. (1995) Endothelin receptor subtypes in resistance arteries from humans and rats. Cardiovasc. Res. 29: 532-535.
76. De Nucci, G., Thomas, R., D'Orleans-Juste, P., Antunes, E., Walder, C., Warner, T. D. and Vane, J. R. (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA 85: 9797-9800.
77. Descombes, J-J., Mennecier, P., Versluys, D., Barou, V., Nanteuil, G., Laubie, M. and Verbeuren, T. J. (1995) S17162 is a novel selective inhibitor of big ET-1 responses in the rat. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S61-S64.
78. Dhurandhar, R. W., Watt, D. L., Silver, M. D., Trimble, A. S. and Adelman, A. G. (1972) Prinzmetal's variant form of angina with arteriographic evidence of coronary arterial spasm. Am. J. Cardiol. 30: 902-905.
79. Dieguez, G., Garcia, J. L., Fernandez, N., GarciaVillalon, A. L., Monge, L. and Gomez, B. (1992) Cerebrovaseular and coronary effects of endothelin-1 in the goat. Am. J. Physiol. 263: R834-R839.
80. A/B endothelin receptor-selective antagonist. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S358-S361.
81. Dohi, Y., Criscione, L. and Lüscher, T. F. (1991) Renovascular hypertension impairs formation of endothelium-derived relaxing factors and sensitivity to endothelin-1 in resistance arteries. Br. J. Pharmacol. 104: 349-354.
82. Doht, Y., Criscione, L., Pfeiffer, K. and Lüscher, T. F. (1992) Normalization of endothelial dysfunction of hypertensive mesenteric resistance arteries by chronic therapy with benazapril or nifedipine. J. Am. Coll. Cardiol. 19 (Suppl. S): 226A.
83. D'Orleans-Juste, P., Telemaque, S. and Claing, A. (1991) Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro. Br. J. Pharmacol. 104: 440-444.
84. Douglas, S. A. and Hiley, C. R. (1991) Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21 ) and other endothelin-related peptides in the rat. Br. J. Pharmacol. 104: 311-320.
85. Douglas, S. A., Edwards, R. M., Elliot, J. D. and Ohlstein, E. H. (1995a) In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670. Br. J. Pharmacol. 114: 405-413.
86. A receptor antagonism with BQ-123 is insufficient to inhibit angioplasty induced neointima formation in the rat. Cardiovasc. Res. 29: 641-646.
87. Eguchi, S., Hirata, Y., Imai, T., Kanno, K. and Marumo, F. (1994) Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology 134: 222-228.
88. Eichler, H-G., Ford, G. A., Blaschke, T. F., Swislocki, A. and Hoffman, B. B. (1989) Responsiveness of superficial hand veins to phenylephrine in essential hypertension: alpha adrenergic blockade during prazosin therapy. J. Clin. Invest. 83: 108-112.
89. Elshourbagy, N. A., Lee, J. A., Korman, D. R., Nuthalaganti, P., Sylvester, D. R., Dilella, A, G., Sutiphong, J. A., Bergsma, D. J., Kumar, C. S. and Nambi, P. (1992) Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum. Mol. Pharmacol. 41: 465-473.
90. Elshourbagy, N. A., Korman, D. R., Wu, H. L., Sylvester, D. R., Lee, J. A., Nuthalaganti, P., Bergsma, D. J., Kumar, C. S. and Nambi, P. (1993) Molecular characterization and regulation of the human endothelin receptors. J. Biol. Chem. 268: 3873-3879.
91. Elton, T. S., Oparil, S., Taylor, G. R., Hicks, P. H., Yang, R. H., Jin, H. and Yiu, F. C. (1992) Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. Am. J. Physiol. 263: R1260-R1264.
92. Emori, T., Hirata, Y., Ohta, K., Kanno, K., Eguchi, S., Imai, T., Shichiri, M. and Marumo, F. (1991) Cellular mechanisms of endothelin-1 release by angiotensin and vasopressin. Hypertension 18: 165-170.
93. Emori, T., Hirata, Y., Imai, T., Ohta, K., Kanno, K., Eguchi, S. and Marumo, F. (1992) Cellular mechanism of thrombin on endothelin-1 biosynthesis and release in bovine endothelial cell. Biochem. Pharmacol. 44: 2409-2411.
94. Emoto, N. and Yanagisawa, M. (1995) Endothelin-converting enzyme is a membrane bound, phosphoramidon sensitive metalloprotease with acidic pH optimum. J. Biol. Chem. 270: 15262-15268.
95. Erhardt, P. W. (1992) Endothelin structure and structure-activity relationships. In: Endothelin, pp. 41-57, Rubanyi, G. M. (ed.) Oxford University Press, New York.
96. Ezra, D., Goldstein, R. E., Czaja, J. F. and Feuerstein, G. Z. (1989) Lethal ischaemia due to intracoronary endothelin in pigs. Am. J. Physiol. 257: H339-H343.
97. Fagny, C., Michel, A., Nortier, J. and Deschodt-Lanckman, M. (1992) Enzymatic degradation of endothelin-1 by activated human polymorphonuclear neutrophils. Regul. Pept. 42: 1-2.
98. Ferro, C. J., Haynes, W. G., Hand, M. F. and Webb, D. J. (1996) Are the vascular endothelin and nitric oxide systems involved in the pathophysiology of essential hypertension? Eur. J. Clin. Invest. 26 (Suppl. 1): A51.
99. Filep, J. G. Herman, F., Battistini, B., Chabrier, P. E., Braquet, P. and Sirois P. (1991a) Antiaggregatory and hypotensive effects of endothelin-1 in beagle dogs: role for prostacyclin. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S216-S218.
100. Filep, J. G., Sirois, M. G., Rousseau, A., Fournier, A. and Sirois, P. (1991b) Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. Br. J. Pharmacol. 104: 797-804.
101. Filep, J. G., Foldes-Filep, E., Rousseau, A., Sirois, P. and Fournier, A. (1993) Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. Br. J. Pharmacol. 110: 1213-1221.
102. Florijn, K. W., Derkx, F. H. M., Visser, W., Hofman, J. A., Rosmalen, F. M., Wallenburg, H. C. and Schalekamp, M. A. (1991) Plasma immunoreactive endothelin-1 in pregnant women with and without pre-eclampsia. J. Cardiovasc. Pharmacol. 17 (Suppl. 7); S446-S448.
103. Folkow, B. (1978) Cardiovascular structural adaption: its role in the initiation and maintenance of primary hypertension. Clin. Sci. Mol. Med. 55: 3S-22S.
104. Fozard, J. R. and Part, M. L. (1992) The role of nitric oxide in the regional vasodilator effects of endothelin-1 in the rat. Br. J. Pharmacol. 105: 744-750.
105. Francis, G. S., Goldsmith, S. R. and Levine, T. B. (1984) The neurohumoral axis in congestive heart failure. Ann. Intern. Med. 101: 370-377.
106. Frank, H. J. L., Levin, E. R., Hu, R. M. and Pedram, A. (1993) Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology 133: 1092-1097.
107. Frelin, C., Ladoux, A., Marsault, R. and Vigne, P. (1991) Functional properties of high-and low-affinity receptor subtypes for ET-3. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S131-S133.
108. Fujimoto, M., Mihara, S. Nakajima, S., Ueda, M., Nakamura, M. and Sakurai, K. (1992) A novel non-peptide endothelin antagonist isolated from bayberry, Myrica cerifera. FEBS Lett. 305: 41-44.
109. Fukami, T., Hayama, T., Amano, Y., Nakamura, Y., Arai, Y., Matsuyama, K., Yano, M. and Ishikawa, K. (1994) Aminophosphonate endothelin-converting enzyme inhibitors: potency enhancing and selectivity improving modifications of phosphoramidon. Bioorg. Med. Chem. Lett. 4: 1257-1262.
110. Fukami, T., Nagase, T., Fujita, K., Hayama, T., Niiyama, K., Mase, T., Nakajima, S., Fukuroda, T., Saeki, T., Nishikibe, M., Ihara, M., Yano, M. and Ishikawa, K. (1995a) Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists. J. Med. Chem. 38: 4309-4324.
111. Fukami, T., Yamakawa, T., Kojima, H., Amano, Y., Ihara, M., Yano, M. and Ishikawa, K. (1995b) Synthesis of 2-substituted D-tryptophan-containing peptide derivatives with endothelin receptor antagonist activity. Bioorg. Med. Chem. Lett. 5: 1483-1488.
112. Fukuroda, T., Noguchi, T., Tsuchida, S., Nishikibe, M., Ikemoto, F., Okada, K. and Yano, M. (1990) Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem. Biophys. Res. Commun. 172: 390-395.
113. B receptors in rats. Biochem. Biophys. Res. Commun. 199: 1461-1465.
114. Furchgott, R. and Zawadski, J. (1980) The obligatory role of endothelial cells in relaxation of arterial smooth muscle to acetylcholine. Nature 228: 373-376.
115. Fyhrquist, F., Saijonmaa, O., Metsarinne, K., Tikkanen, I., Rosenlof, K. and Tikkanen, T. (1990) Raised plasma endothelin-1 concentration following cold pressor test. Biochem. Biophys. Res. Commun. 169: 217-221.
116. 125I]endothelin-1 by liver-derived cells. Arch. Biochem. Biophys. 305: 38-46.
117. Garcia, R., Lachance, D. and Thibault, G. (1990) Positive inotropic action, natriuresis and atrial natriuretic factor release induced by endothelin in the conscious rat. J. Hypertens. 8: 725-731.
118. G-monomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur. J. Pharmacol. 171: 237-240.
119. Gardiner, S. M., Compton, A. M. and Bennett, T. (1990a) Effect of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin. Br. J. Pharmacol. 100: 158-162.
120. Gardiner, S. M., Compton, A. M. and Bennett, T. (1990b) Effects of endothelin-1 on cardiac output in conscious rats in the absence and presence of cardiac autonomic blockade. Eur. J. Pharmacol. 183: 2232-2233.
121. Gardiner, S. M., Compton, A. M., Kemp, P. A. and Bennett, T. (1990c) Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester. Br. J. Pharmacol. 101: 632-639.
122. Gardiner, S. M., Compton, A. M., Kemp, P. A. and Bennett, T. (1991) The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin-1 [1-38] in conscious rats. Br. J. Pharmacol. 103: 2009-2015.
123. Gardiner, S. M., Kemp, P. A. and Bennett, T. (1992) Inhibition by phosphoramidon of the regional haemodynamic effects of proendothelin-2 and-3 in conscious rats. Br. J. Pharmacol. 107: 584-590.
124. Gardiner, S. M., Kemp, P. A. and Bennett, T. (1993) Regional haemodynamic responses to intravenous and intraarterial endothelin-1 and big endothelin-1 in conscious rats. Br. J. Pharmacol. 110: 1532-1536.
125. B-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats. Br. J. Pharmacol. 112: 823-830.
126. 11.15]Ac-endothelin-1 (6-21) in conscious rats. Br. J. Pharmacol. 112: 477-486.
127. A receptor antagonist, BQ-123 on ischaemic arrythmias in anesthetised rats. J. Cardiovasc. Pharmacol. 25: 634-642.
128. Gasic, S., Wagner, O. F., Vierhapper, H., Nowotny, P. and Waldhausl, W. (1992) Regional hemodynamic effects and clearance of endothelin-1 in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide. J. Cardiovasc. Pharmacol. 19: 176-180.
129. Gerbes, A. L., Moller, S., Gulberg, V. and Henriksen, J. H. (1995) Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology 21: 735-739.
130. Giaid, A., Kimura, S., Chen, M., Goodyer, C., Masaki, T. and Cantin, M. (1991) Immunocytochemical localisation of endothelin-like immunoreactivity. Hypertension 17: 444.
131. Giaid, A., Saleh, D., Yanagisawa, M. and Forbes, R. (1995) Endothelin-1 immunoreactivity and mRNA in transplanted human heart. Transplantation 59: 1308-1313.
132. Gillespie, M., Owasoyo, J., McMurty, I. and O'Brien, R. (1986) Sustained coronary vasoconstriction provoked by a peptidergic substance released from endothelial cells in culture. J. Pharmacol. Exp. Ther. 236: 339-343.
133. Goligorsky, M. S., Iijima, K., Morgan, M., Yanagisawa, M., Masaki, T., Lin, L., Nasjletti, A., Kaskek, F., Frazer, M. and Badr, K. F. (1991) Role of endothelin in the development of Dahl hypertension. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S484-S491.
134. Granstam, E., Wang, L. and Bill, A. (1993) Vascular effects of endothelin-1 in the cat: modification by indomethacin and L-NAME. Acta Physiol. Scand. 148: 165-176.
135. Gray, G. A. (1995) Pharmacological characterization of endothelin receptors. In: Pharmacology and Molecular Biology of the Endothelins, pp. 61-94, Gray, G. A. and Webb, D. J. (eds.) RG Landes Co., Austin.
136. Gray, G. A., Löffler, B. M. and Clozel, M. (1994) Characterization of endothelin receptors mediating contraction of the rabbit saphenous vein. Am. J. Physiol. 266: H959-H966.
137. Grover, G. J., Sleph, P. G., Fox, M. and Prippodu, N. C. (1992) Role of endothelin 1 and big endothelin 1 in modulating coronary vascular tone, contractile function and severity of ischaemia in rat hearts. J. Pharmacol. Exp. Ther. 263: 1074-1082.
138. Grover, G. J., Dzwonczyk, S. and Parham, C. S. (1993) The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc. Res. 27: 1613-1618.
139. 125I-endothelin-1 binding to brain and cardiac membranes from normotensive and spontaneously hypertensive rats. Eur. J. Pharmacol. 177: 205-209.
140. Gui, G., Xu, D., Emoto, N. and Yanagisawa, M. (1993) Intracellular localization of membrane-bound endothelin-converting enzyme from rat lung. J. Cardiovasc. Pharmacol. 22: S53-S56.
141. Haak, T., Junmann, E., Felber, A., Hillman, U. and Usadel, K. H. (1992) Increased plasma levels of endothelin in diabetic patients with hypertension. Am. J. Hypertens. 5: 161-166.
142. Haefeli, W. E., Linder, L. and Kiowski, W. (1993) In vivo properties of endothelin-1 and endothelin-3 in human hand veins and its reversal by bradykinin and verapamil. Hypertension 22: 343.
143. Harrison, V. J., Corder, R., Anggard, E. E. and Vane, J. R. (1993) Evidence for vesicles that transport endothelin-1 in bovine aortic endothelial cells. J. Cardiovasc. Pharmacol. 2: S57-S60.
144. A receptor abrogated the binding activity to ET-1. Biochem. Biophys. Res. Commun. 187: 1241-1248.
145. A receptor required for ligand binding and signal transduction. Cell. Mol. Biol. Res. 39: 3-12.
146. Haynes, W. G. and Webb, D. J. (1993a) Endothelium-dependent modulation of responses to endothelin-1 in human hand veins. Clin. Sci. 84: 427-433.
147. Haynes, W. G. and Webb, D. J. (1993b) The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin. Sci. 84: 485-500.
148. Haynes, W. G. and Webb, D. J. (1993c) Venoconstriction to endothelin-1 in humans: the role of calcium and potassium channels. Am. J. Physiol. 265: H1676-H1681.
149. Haynes, W. G. and Webb, D. J. (1994) Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344: 852-854.
150. Haynes, W. G., Noon, J., Walker, B. R. and Webb, D. J. (1993) Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J. Hypertens. 11: 1375-1380.
151. Haynes, W. G., Hand, M., Johnstone, H., Padfield, P. L. and Webb, D. J. (1994) Direct and sympathetically mediated venoconstriction in essential hypertension: enhanced responses to endothelin-1. J. Clin. Invest. 94: 1359-1364.
152. B receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92: 357-363.
153. Haynes, W. G., Ferro, C. J., O'Kane, K. P. G., Somerville, D., Lomax, C. C. and Webb, D. J. (1996) Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in man. Circulation 93: 1860-1870.
154. Hayzer, D. J., Rose, P. M., Lynch, J. S., Webb, M. L., Kienzle, B. K., Liu, E. C. K., Bogosian, E. A., Brinson, E. and Runge, M. S. (1992) Cloning and expression of a human endothelin receptor: subtype A. Am. J. Med. Sci. 304: 231-238.
155. He, J. X., Cody, W. L., Flynn, M. A., Welch, K. M., Reynold, E. and Doherty, A. M. (1995) Res 701-1, synthesis and a re-evaluation of its effects on the endothelin receptor. Bio. Med. Chem. Letts. 5: 621-626.
156. Hemsen, A., Ahlborg, G., Ottoson-Seeberger, A. and Lundberg, J. M. (1995) Metabolism of big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin (1-21). Regul. Pept. 55: 287-297.
157. Mickey, K. A., Rubanyi, G., Paul, R. and Highsmith, R. (1985) Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am. J. Physiol. 248: C550-C556.
158. Hide, E. J., Piper, J. and Thiemermann, C. (1995) Endothelin-1 reduction of myocardial infarct size by activation of ATY-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion. Br. J. Pharmacol. 16: 2597-2602.
159. Hilkert, R. J., Lee, M-U. and Quertermous, T. (1992) Genetic regulation of endothelin-1 in vascular endothelial cells. Trends Cardiovasc. Med. 2: 129-133.
160. Hirata, K., Matsuda, T., Akita, H., Yokoyama, M. and Fukuzaki, H. (1990) Myocardial ischaemia induced by endothelin in the intact rabbit: angiographic analysis. Cardiovasc. Res. 24: 879-883.
161. Hirata, Y., Yoshimi, H., Takaichi, S., Yanagisawa, M. and Masaki, T. (1988) Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smoth muscle cells. FEBS Lett. 239: 13-17.
162. Hirata, Y., Kanno, K., Watanabe, T., Kumagaye, S., Nakajima, K., Kimura, T., Sakakibara, S. and Marumo, F. (1990) Receptor binding and vasoconstrictor activity of big endothelin. Eur. J. Pharmacol. 176: 225-228.
163. Hisaki, K., Matsumura, Y., Nishiguchi, S., Fujita, K., Takaoka, M. and Morimoto, S. (1993) Endothelium independent pressor effect of big endothelin-1 and its inhibition by phosphoramidon in rat mesenteric artery. Eur. J. Pharmacol. 241: 75-81.
164. Hoehe, M. R., Ehrenreich, H., Otterud, B., Caenazzo, L., Plaetke, R., Zander, H. and Leppert, M. (1993) The human endothelin-1 gene (EDN1) encoding a peptide with potent vasoactive properties maps distal to HLA on chromosome arm 6p in close linkage to D6S89. Cytogenet. Cell Genet. 62: 631-635.
165. Hoffman, A., Grossman, E. and Keiser, H. R. (1990) Opposite effects of endothelin-1 and big-endothelin-(1-39) on renal function in rats. Eur. J. Pharmacol. 182: 603-606.
166. Hori, S., Komatsu, Y., Shigemoto, R., Mizuno, N. and Nakanishi, S. (1992) Distinct tissue distribution and cellular location of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 130: 1885-1895.
167. Horio, T., Kohno, M. and Takeda, T. (1992) Effects of arginine vasopressin, angiotensin II and endothelin-1 on the release of brain natriuretic peptide in vivo and in vitro. Clin. Exp. Pharmacol. Physiol. 19: 575-582.
168. Hosada, K., Nakao, K., Arai, H., Suga, S-I., Ogawa, Y., Mukoyama, M., Shirakami, G., Saito, Y., Nakanishi, S. and Imura, H. (1991) Cloning and expression of human endothelin-1 receptor cDNA. FEBS Lett. 287: 223-226.
169. Hosada, K., Nakao, K., Tamura, N., Arai, H., Ogawa, Y., Suga, S., Nakanishi, S. and Imura, H. (1992) Organization, structure, chromosomal assignment and expression of the human endothelin-A receptor. J. Biol. Chem. 267: 18797-18804.
170. Howard, P., Plumpton, C. and Davenport, A. (1992) Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J. Hypertens. 10: 1379-1366.
171. Huggins, J. P., Pelton, J. T. and Miller, R. C. (1993) The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmacol. Ther. 59: 55-123.
172. Hughes, A. K., Cline, R. C. and Kohan, D. E. (1992) Alterations in renal endothelin-1 production in the spontaneously hypertensive rat. Hypertension 20: 666-673.
173. Ignarro, L., Buga, G., Wood, K., Byrns, R. and Chaudhuri, G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein appears to be nitric oxide. Proc. Natl. Acad. Sci. USA 84: 9265-9269.
174. A antagonist isolated from Streptomyces misakiensis. Biochem. Biophys. Res. Commun. 178: 132-137.
175. A receptor. Life Sci. 50: 247-255.
176. B receptors. Life Sci. 51: 47-52.
177. B-mediated blood pressure responses in rats. J. Pharmacol. Exp. Ther. 270: 728-733.
178. Ikura, T., Sawamura, T., Shiraki, T., Hosokawa, H., Kido, T., Hoshikawa, H., Shimada, K., Tanzawa, T., Kobayashi, S., Miwa, S. and Masaki, T. (1994) cDNA cloning and expression of bovine endothelin converting enzyme. Biochem. Biophys. Res. Commun. 203: 1417-1422.
179. Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, S., Miyauchi, T., Goto, K. and Masaki, T. (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA 86: 2863-2867.
180. Ishikawa, K., Ihara, M., Noguchi, K., Mase, T., Mino, N., Saeki, T., Fukuroda, T., Fukami, T., Ozaki, S., Nagase, T., Nishikibe, M. and Yano, M. (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA 91: 4892-4896.
181. Ito, H., Hirata, Y., Adachi, S., Tanaka, M., Tsujino, M., Koike, A., Nogami, A., Marumo, F. and Hiroe, M. (1993) Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest. 92: 398-403.
182. Itoh, S. and van Den Busse, H. (1991) Sensitization of baroreceptor reflex by central endothelin in conscious rats. Am. J. Physiol. 260: H1106-H1112.
183. A receptor antagonist, BQ-485, and its preventative effect on experimental vasospasm in dogs. Biochem. Biophys. Res. Commun. 195: 969-975.
184. Itoh, Y., Yanagisawa, M., Ohkubo, S., Kimura, C., Kosaka, T., Inoue, A., Ishida, N., Mitsui, Y., Onda, H., Fujino, M. and Masaki, T. (1988) Cloning and sequencing of cDNA encoding the precursor of human endothelium-derived constrictor peptide, endothelin: identity of human and porcine endothelin. FEBS Lett. 231: 440-444.
185. Jackman, H. L., Morris, P. W., Deddish, P. A., Skidgel, R. A. and Erdos, E. G. (1992) Inactivation of endothelin I by deamidase (lysosomal protective protein). J. Biol. Chem. 267: 2872-2875.
186. Jackman, H. L., Morris, P. W., Rabito, S. F., Johansson, G. B., Skidgel, R. A. and Erdos, E. G. (1993) Inactivation of endothelin-1 by an enzyme of the vascular endothelial cells. Hypertension 21: II-925-II-928.
187. James, A. F., Xie, L-H., Fujitani, Y., Hayashi, S. and Hories, M, (1994) Inhibition of the cardiac protein kinase A-dependent chloride conductance by endothelin-1. Nature 370: 297-300.
188. Janas, J., Sitkiewicz, D., Warnawin, K. and Janas, R. M. (1994) Characterization of a novel, high-molecular weight, acidic, endothelin-1 inactivating metalloendopeptidase from the rat kidney. J. Hypertens. 22: 1155-1162.
189. Jones, L. G., Rozich, J. D., Tsutsui, H. and Cooper, G. (1992) Endothelin stimulates multiple responses in isolated adult ventricular cardiac myocytes. Am. J. Physiol. 263: H1447-H1454.
190. Kadowitz, P. J., McMahon, T. J., Hood, J. S., Feng, C. J., Minkes, R. K. and Dyson, M. C. (1991) Pulmonary vascular and airway responses to endothelin-1 are mediated by different mechanisms in the cat. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S374-S377.
191. B receptor subtype mRNA by angiotensin II in rat cardiomyocytes. Biochem. Biophys. Res. Commun. 194: 1282-1287.
192. Karet, F. E. and Davenport, A. P. (1995) Comparative quantification of endothelin receptor mRNA in human kidney: new tools for direct investigation of human tissue. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S268-S271.
193. Karne, S., Jayawickreme, C. K. and Lerner, M. R. (1993) Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J. Biol. Chem. 268: 19126-19133.
194. Kashiwabara, T., Inagaki, Y., Ohta, H., Iwamatsu, A., Nomizu, M., Morita, A. and Nishikori, K. (1989) Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent presser effect in vivo. FEBS Lett. 247: 73-76.
195. Kaufmann, H., Oribe, E. and Oliver, J. A. (1991) Plasma endothelin during upright tilt: relevance lor orthostatic hypotension? Lancet 338: 1542-1545.
196. Kaw, S., Hecker, M. and Vane, J. R. (1992) The two-step conversion of big endothelin-1 to endothelin-1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 89: 6886-6890.
197. Kawaguchi, H., Sawa, H. and Yasuda, H. (1991) Effect of endothelin on angiotensin converting enzyme in cultured pulmonary artery endothelial cells. J. Hypertens. 9: 171-174.
198. B. Biochem. Biophys. Res. Commun. 200: 1708-1712.
199. Kimura, S., Kasuya, Y., Sawamura, T., Shinmi, O, Sugita, Y., Yanagisawa, M., Goto, K. and Masaki, T. (1988) Structure-activity relationships of endothelin: importance of the C-terminal moiety. Biochem. Biophys. Res. Commun. 156: 1182-1186.
200. King, A. J., Brenner, B. M. and Anderson, S. (1989) Endothelin: a potent renal and systemic vasoconstrictor peptide. Am. J. Physiol. 256: F1051-F1058.
201. Kiowski, W., Luscher, T. F. and Linder, L. (1991) Endothelin-1-induced vasoconstriction in humans: reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 83: 469-475.
202. Kiowski, W., Bertel, O., Sutsch, G., Hunziker, P., Müller, P., Schmitt, R., Kim, J. and Oechslin, E. (1995) Vasodilator effects of the endothelin-1 antagonist bosentan in patients with severe chronic heart failure. J. Am. Coll. Cardiol. Special Issue: 44th Annual Scientific Session, American College of Cardiology, New Orleans, March 19-25, 1995, Abstract 779-1.
203. A receptor distribution. J. Cardiovasc. Pharmacol. 22 (Suppl. 8): S128-S131.
204. Kitamura, K., Tanaka, T., Kato, J., Ogawa, T., Eto, T. and Tanaka, K. (1989) Immunoreactive endothelin in rat kidney inner medulla: marked decrease in spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 162: 38-44.
205. Kloog, Y., Ambar, I., Sokolovky, M., Kochva, E., Bdolah, A. and Wollberg, Z. (1988) Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science 242: 268-270.
206. Kohno, M., Murakawa, K., Yasunari, K., Yokokawa, K., Horio, T., Kurihara, N. and Takeda, T. (1989) Prolonged blood pressure elevation after endothelin administration in bilaterally nephrectomised rats. Metabolism 38: 712-713.
207. Kohno, M., Yasunari, K., Murakawa, K-I., Yokokawa, K., Horio, T., Fukui, T. and Takeda, T. (1990) Plasma immunoreactive endothelin in essential hypertension. Am. J. Med. 88: 614-618.
208. Kohno, M., Murakawa, K-I., Horio, T., Yokokawa, K., Yasunari, K., Fukui, T. and Takeda, T. (1991) Plasma immunoreactive endothelin-1 in experimental malignant hypertension. Hypertension 18: 93-100.
209. Kohno, M., Horio, T., Ikeda, M., Yokokawa, K., Fukui, T., Yasunari, K., Kurihara, N. and Takeda, T. (1992) Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int. 42: 860-866.
210. Kosuka, M., Ito, T., Hirose, S., Lodhi, K. M. and Hagiwara, H. (1991) Purification and characterization of bovine lung endothelin receptor. J. Biol. Chem. 266: 16892-16896.
211. Koyama, H., Tabata, T., Nishzawa, Y., Inoue, T., Morii, H. and Yamaji, T. (1989) Plasma endothelin levels in patients with uraemia. Lancet 333: 991-992.
212. Krause, S. M., Lynch, J. J., Stabilato, I. I. and Woltman, R. F. (1994) Intravenous administration of the endothelin antagonist BQ-123 does not ameriolate myocardial ischaemic injury following acute coronary artery occlusion in the dog. Cardiovasc. Res. 28: 1672-1678.
213. Krystek, S. R., Patel, P. S., Rose, P. M., Fisher, S. M., Kienzle, B. K., Lach, D. A., Liu, E. C. K., Lynch, J. S., Novotny, J. and Webb, M. L. (1994) Mutation of peptide binding site in transmembrane region of a G-protein-coupled receptor accounts for endothelin receptor subtype selectivity. J. Biol. Chem. 269: 12383-12386.
214. Kuchan, M. J. and Frangos, J. A. (1993) Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am. J. Physiol. 264: H150-H156.
215. Kumar, C., Mwangi, V., Nuthalaguni, P., Wu, H-L., Pullen, M., Brun, K., Aiyar, H., Morris, R. A., Naughton, R. and Nambi, P. (1994) Cloning and characterization of a novel endothelin receptor from Xenopus heart. J. Biol. Chem. 269: 13414-13420.
216. Kurihara, H., Yamaoki, K., Nagai, R., Yoshizmi, M., Takaku, F., Satoh, H., Inui, J. and Yazaki, Y. (1989) Endothelin: a potent vasoconstrictor associated with coronary vasospasm. Life Sci. 44: 1937-1944.
217. Kurihara, Y., Kurihara, H., Suzuki, H., Kodama, T., Maemura, K., Nagal, R., Oda, H., Kuwaki, T., Cao, W. H., Kamada, N., Jishage, K., Ouchi, Y. and Azumo, S. (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703-710.
218. Kurose, I., Miura, S., Suematsu, M., Fukumura, D., Nagata, H., Sckizuka, E. and Tsuchiya, M. (1991) Involvement of platelet-activating factor in endothelin-induced vascular smooth muscle cell contraction. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S279-S283.
219. Lam, K. T., Williams, D. L., Sigmund, J. M., Sanches, M., Genilloud, O., Kong, Y. L., Steven-Miles, S., Huang, L. and Garrity, G. M. (1992) Cochinmicins, novel and potent cyclodepsipeptide endothelin antagonists from a Microbiospora sp. 1. Production, isolation and characterization. J. Antibiot. 45: 1709-1716.
220. Laporte, S., Denault, J. B., D'Orleans-Juste, P. and Leduc, R. (1993) Presence of furin mRNA in cultured bovine endothelial cells and possible involvement of furin in the processing of the endothelin precursor. J. Cardiovasc. Pharmacol. 22 (Suppl. 8) S7-S10.
221. Larivière, R., Thibault, G. and Schiffrin, E. L. (1993) Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive rats but not in spontaneously hypertensive rats. Hypertension 21: 294-300.
222. Lechleitner, P., Genser, N., Mair, J., Maier, J., Arther, D., Worzak, E., Dienstl, F. and Puschendorf, B. (1993) Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysis. Clin. Chem. 39: 955-959.
223. Lee, J. A., Elliot, J. D., Sutiphong, J. A., Preisen, W. J., Ohlstein, E. H., Stadel, J. M., Gleason, J. G. and Peishoff, C. E. (1994) Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor. Proc. Natl. Acad. Sci. USA 91: 7164-7168.
224. Lee, M-E., Bloch, K., Clifford, J. and Quertermous, T. (1990) Functional analysis of the endothelin-1 promoter: evidence for an endothelial cell-specific cis-acting sequence. J. Biol. Chem. 10: 10446-10450.
225. Lee, M-E., Dhadly, M. S., Temizer, D. H., Clifford, J. A., Yoshizumi, M. and Quertermous, T. (1991a) Regulation of endothelin-1 gene expression by Fos and Jun. J. Biol. Chem. 266: 19304-19309.
226. Lee, M-E., Temiser, D., Clifford, J. and Quertermous, T. (1991b) Cloning of the GATA-binding protein that regulates endothelin-1 gene expresion in endothelial cells. J. Biol. Chem. 266: 16188-16192.
227. Leifeldt, L., Böcker, W., Schönfelder, G., Zintz, M. and Paul, M. (1995) Regulation of the endothelin system in transgenic rats expressing the human endothelin-2 gene, J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S32-S33.
228. Lerman, A., Edwards, B. S., Hallett, J. W., Heublam, D. M., Sandberg, S. M. and Burnett, J. C. (1991a) Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Engl. J. Med. 325: 997-1001.
229. Lerman, A., Hildebrand, F. L., Aarhus, L. L. and Burnett, J. C. (1991b) Endothelin has biological actions at pathophysiological concentrations. Circulation 83: 1808-1814.
230. Lin, H. Y., Kaji, E. H., Winkel, G. K., Ives, H. E. and Lodish, H. F. (1991) Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc. Natl. Acad. Sci. USA 88: 3185-3189.
231. Lippton, H. L., Cohen, G. A., Knight, M., McMurty, I. F., Gillot, D., Arena, F., Summer, W. and Hyman, A. L. (1991) Evidence for distinct endothelin receptors in the pulmonary vascular bed in vivo. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S370-S373.
232. Liu, J., Chen, R., Casley, D. J. and Nayler, W. G. (1990) Ischaemia and reperfusion increase [125I] labelled endothelin-1 binding in rat cardiac membranes. Am. J. Physiol. 258: 829-835.
233. Llorens-Cortes, C., Huang, H., Vicart, P., Gasc, J. M., Paulin, D. and Corvol, P. (1992) Identification and characterisation of neutral endopeptidase in endothelial cells from venous or arterial origins. J. Biol. Chem. 267: 14012-14018.
234. Löffler, B. M., Kalina, B. and Kunze, H. (1991) Partial characterization and subcellular distribution patterns of endothelin-1, -2 and -3 binding sites in human liver. Biochem. Biophys. Res. Commun. 181: 840-845.
235. Löffler, B. M., Breu, V. and Clozel, M. (1993) Effect of endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett. 333: 108-110.
236. Love, M. P., Haynes, W. G., Webb, D. J. and McMurray, J. (1994) Anti-endothelin therapy is of potential benefit in heart failure. Circulation 90: 1-547.
237. Love, M. P., Haynes, W. G., Gray, G. A., Webb, D. J. and McMurray, J. J. V. (1996) Endothelin-converting enzyme inhibition and endothelin receptor blockade in congestive heart failure. Circulation, in press.
238. Lüscher, T. F. (1991) Endothelin, key to coronary vasospasm? Circulation 83: 701-703.
239. Lüscher, T. F. (1992) Heterogeneity of endothelial dysfunction in hypertension. Eur. Heart J. 13: 50-55.
240. Lüscher, T. F. and Wenzel, R. R. (1995) Endothelin and endothelin antagonists: pharmacology and clinical implications. Agents Actions 4: 237-253.
241. MacLean, M. R. and McGrath, J. C. (1990) Effects of endothelin-1 on isolated vascular beds from normotensive and spontaneously hypertensive rats. Eur. J. Pharmacol. 190: 263-267.
242. Maemura, K., Kurihara, H., Kurihara, Y., Kuwaki, T., Kumada, M. and Yazaki, Y. (1995) Gene expression of endothelin isoforms and receptors in endothelin-1 knockout mice. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S17-S21.
243. Maggi, C. A., Giuliani, S., Patacchini, R., Rovero, P., Giachetti, A. and Meli, A. (1989) The activity of peptides of the endothelin family in various mammalian smooth muscle preparations. Eur. J. Pharmacol. 174: 23-31.
244. Maguire, J., Kuc, R. E., O'Reilly, G. and Davenport, A. P. (1994) Vasoconstrictor endothelin receptors characterised in human renal artery and vein in vitro. Br. J. Pharmacol. 113: 49-54.
245. Malek, A. M., Greene, A. L. and Izumo, S. (1993) Regulation of endothelin-1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc. Natl. Acad. Sci. USA 90: 5999-6003.
246. Masaoka, H., Suzuki, R., Hirata, Y., Emori, T., Marumo, F. and Hirakawa, K. (1989) Raised plasma endothelin levels in aneurysmal subarachnoid haemorrhage. Lancet ii: 1402.
247. Matsumoto, H., Suzuki, N., Kitada, C. and Fujino, M. (1994) Endothelin family peptides in human plasma and urine: their molecular forms and concentrations. Peptides 15: 505-510.
248. Matsumura, K., Abe, I., Tsuchihashi, T., Tominga, M., Kobayashi, K. and Fujishima, M. (1991) Central effect of endothelin on neurohormonal responses in conscious rabbits. Hypertension 17: 1192-1196.
249. Matsumura, Y., Ikegawa, R., Hisaki, K., Tsukuhara, Y., Takaoka, M. and Morimoto, S. (1990) Conversion of big-endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett. 272: 166-170.
250. Matsumura, Y., Ikegawa, R., Suzuki, Y., Takaoka, M., Uchida, T., Kido, H., Shinyama, H., Hayashi, K., Watanbe, M. and Morimoto, S. (1991a) Phosphoramidon prevents cerebral vasospasm following subarachnoid haemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci. 49: 841-848.
251. Matsumura, Y., Ikegawa, R., Tsukuhara, Y. and Morimoto, S. (1991b) N-ethylamide differentiates endothelin converting activity by two types of metalloproteinases derived from vascular endothelial cells. Biochem. Biophys. Res. Commun. 178: 531-538.
252. Matsumura, Y., Fujita, K., Takaoka, M. and Morimoto, S. (1993) Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized rats. Eur. J. Pharmacol 230: 89-93.
253. Matsuura, A., Okumura, H., Asakura, R., Ashizawa, N., Takahashi, M., Kobayashi, F., Ashikawa, N. and Arai, K. (1993) Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors. Jpn. J. Pharmacol. 63: 187-193.
254. Matsuyama, K., Yasue, H., Okumura, K., Saito, Y., Nakao, K., Shirakami, G. and Imura, H. (1991) Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina. Am. J. Cardiol. 68: 991-995.
255. Mayberg, M. R., Okada, T. and Bark, D. H. (1990) The role of haemoglobin in the arterial narrowing after subarachnoid haemorrhage. J. Neurosurg. 72: 634-640.
256. B receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S169-S176.
257. McMahon, E. G., Fok, K. F., Moore, W. M., Smith, C. E., Siegel, N. R. and Trapani, A. J. (1989) In vitro and in vivo activity of chymotrypsin-activated big endothelin (porcine 1-40). Biochem. Biophys. Res. Commun. 161: 406-413.
258. McMahon, E. G., Palomo, M. A. and Moore, W. M. (1991) Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S29-S33.
259. McMahon, E. G., Palomo, M. A., Brown, M. A., Bertenshaw, S. R. and Carter, J. S. (1993) Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats. Am. J. Hypertens. 6: 667-673.
260. McMurdo, L., Corder, R., Thiemermann, C. and Vane, J. R. (1993) Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor. Br. J. Pharmacol. 108: 557-561.
261. A receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion. Br. J. Pharmacol. 112: 75-80.
262. McMurray, J. J., Ray, S. G., Abdullah, I., Dargie, H. J. and Morton, J. J. (1992) Plasma endothelin in heart failure. Circulation 85: 1374-1379.
263. Mebaaza, A., Mayoux, E. and Maeda, K. (1993) Paracrine effect of endocardial endothelial cells on myocyte contraction mediated via endothelin. Am. J. Physiol. 265: H1841-H1846.
264. MERCATOR Study Group (1992) Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation 86: 100-110.
265. + ions and endothelin receptor subtypes. Eur. J. Pharmacol. 214: 133-141.
266. Mihara, S-I., Nakajima, S., Matumura, S., Kohoike, T. and Fujimoto, M. (1994) Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139. J. Pharmacol. Exp. Ther. 268: 1122-1128.
267. Miller, D., Waters, D. D. and Wamica, W. (1981) Is variant angina the coronary manifestation of a generalized vasospastic disorder? N. Engl. J. Med. 304: 736-766.
268. Miller, W. L., Redfield, M. M. and Burnert, J. C., Jr. (1989) Integrated cardiac, renal and endocrine actions of endothelin. J. Clin. Invest. 83: 317-320.
269. Miyamori, I., Itoh, Y., Matsubara, T., Koshida, H. and Takeda, R. (1990) Systemic and regional effects of endothelin in rabbits: effects of endothelin antibody. Clin. Exp. Pharmacol. Physiol. 17: 691-696.
270. Miyamori, I., Takeda, Y., Yoneda, T. and Takeda, R. (1991) Endothelin release from mesenteric arteries of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S408-S410.
271. Miyamoto, Y., Yoshimasa, T., Arai, H., Takaya, K., Ogawa, Y., Tanaka, I., Itoh, H. and Nakao, K. (1994) Alternative RNA splicing of the human endothelin-A receptor gene. Circulation 90: 51.
272. Miyauchi, T., Ishikavva, T., Tomobe, Y., Yanagisawa, M., Kinura, S., Sugishita, Y., Ito, I., Goto, K. and Masaki T. (1989a) Characteristics of pressor response to endothelin in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 14: 427-434.
273. Miyauchi, T., Yanagisawa, M., Tomizawa, T., Sufishita, Y., Suzuki, N., Fujino, M., Ajisaka, R., Goto, K. and Masaki, T. (1989b) Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet ii: 53-54.
274. Molenaar, P., O'Reilly, G., Sharkey, A., Kuc, R. E., Harding, D. P., Plumpton, C., Gresham, G. A. and Davenport, A. P. (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circulation 72: 526-538.
275. Moncada, S., Gryglewski, R., Bunting, S. and Vane, J. (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665.
276. A receptor antagonist. Cardiovasc. Drug Rev. 12: 48-69.
277. B-like receptors. Biochem. Biophys. Res. Commun. 184: 100-106.
278. Moreland, S., Abboa-Offei, B. and Seymour, A. (1994) Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature. Br. J. Pharmacol. 112: 704-708.
279. Morita, A., Nomizu, M., Okitsu, M., Horie, K., Yokogoshi, H. and Roller, P. P. (1994) D-ValZZ containing human big endothelin-1 analog, (D-Val22)Big ET-1(16-38), inhibits the endothelin converting enzyme. FEBS Lett. 353: 84-68.
280. Morita, T., Kurihara, H., Maemura, K., Yoshizumi, M. and Yazaki, Y. (1993) Disruption of cytoskeletal structures mediates shear stress-induced endothelin-1 gene expression in cultured porcine aortic endothelial cells J. Clin. Invest. 92: 1706-1712.
281. Mortensen, L. H. and Fink, G. D. (1990) Hemodynamic effect of human and rat endothelin administration into conscious rats. Am. J. Physiol. 258: H362-H368.
282. Mortensen, L. H. and Fink, G. D. (1992a) Salt-dependency of endothelin-induced, chronic hypertension in conscious rats. Hypertension 19: 549-554.
283. Mortensen, L. H. and Fink, G. D. (1992b) Captopril prevents chronic hypertension produced by infusion of endothelin-1 in rats. Hypertension 19: 676-680.
284. Mortensen, L. H., Pawloski, C. M., Kanagy, N. L. and Fink, G. D. (1990) Chronic hypertension produced by infusion of endothelin in rats. Hypertension 15: 729-733.
285. Mugrage, B., Moliterni, J., Robinson, L., Webb, R. L., Shetty, S. S., Lipson, K. E., Chin, M. H., Neale, R. and Cioffi, C. (1993) CGS 27830, a potent nonpeptide endothelin receptor antagonist. FEBS Lett. 3: 2099-2104.
286. Munger, K. A., Takahashi, K., Awazu, M., Frazer, M., Falk, S. A., Conger, J. D. and Badr, K. F. (1993) Maintenance of endothelin-induced renal arteriolar constriction in rats is cyclooxygenase dependent. Am. J. Physiol. 264: F637-F644.
287. Nagayama, Y., Wadsworth, H. L., Chazenbalk, G. D., Russo, D., Seto, P. and Rapoporr, B. (1991) Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function. Proc. Natl. Acad. Sci. USA 88: 902-905.
288. Nakamoto, H., Suzuki, H., Murakami, M., Kageyama, Y., Ohishi, A., Fukuda, K., Hori, S. and Saruta, T. (1989) Effects of endothelin on systemic and renal hemodynamics and neuroendocrine hormones in conscious dogs. Clin. Sci. 77: 567-572.
289. Nakamuta, M., Takayanagi, R., Sakai, Y., Sakamoto, S., Hagiwara, H., Mizuno, T., Saito, Y., Hirose, S., Yamamoto, M. and Nawata, H. (1991) Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor. Biochem. Biophys. Res. Commun. 177: 34-39.
290. Neyses, L., Nouskas, J., Luyken, J., Fronhoffs, S., Oberdorf, S., Pfeifer, U., Williams, R. S., Sukhatme, V. P. and Vetter, H. (1993) Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. J. Hypertens. 11: 927-934.
291. A antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci. 52: 1869-1874.
292. Nishikibe, M., Tsuchida, S., Okada, M., Fukuoda, T., Shimamoto, K., Yano, M., Ishikawa, K. and Ikemoto, F. (1993) Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci. 52: 717-724.
293. Nishimura, M., Takahashi, H., Matsusawa, M., Ikegati, T., Sakamoto, M., Nakanishi, T., Hirabayashi, M. and Yoshimura, M. (1991) Chronic intracerebroventricular infusions of endothelin elevate arterial pressure in rats. J. Hypertens. 9: 71-76.
294. Ogawa, Y., Nakao, K., Arai, H., Nagakawa, O., Hosada, K., Suga, S-I., Nakanishi, S. and Imura, H. (1991) Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem. Biophys. Res. Commun. 178: 248-255.
295. Ohashi, H., Akiyama, H., Nishikori, K. and Mochizuki, J. I. (1992) Asterric acid, a new endothelin binding inhibitor. J. Antibior. 45: 1684-1685.
296. Ohlstein, E. H., Vickery, L., Sauermelch, C. and Willette, R. N. (1990) Vasodilation induced by endothelin: role of EDRF and prostanoids in rat hindquarters. Am. J. Physiol. 259: H1835-H1841.
297. Ohlstein, E. H., Nambi, P., Douglas, S. A., Edwards, R. M., Gellai, M., Lago, A., Leber, J. D., Cousins, R. D., Gao, A., Frazee, J. S., Peishoff, C. E., Bean, J. W., Eggleston, D. S., Elshourbagy, N. A., Kumar, C., Lee, J. A., Yue, T. L. Louden, C. and Elliott, J. D. (1994) SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc. Natl. Acad. Sci. USA 91: 8052-8056.
298. Ohnaka, K., Takayanagi, R., Nishikawa, M., Haji, M. and Nawata, H. (1993) Purification and characterization of a phosphoramidon sensitive endothelin-converting enzyme in porcine aortic endothelium. J. Biol. Chem. 268: 26759-26766.
299. Okada, K., Takada, J., Arai, Y., Matsuyama, K. and Yano, M. (1991) Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme. Biochem. Biophys. Res. Commun. 180: 1019-1023.
300. O'Keefe, S. T., Tsapatsaris, N. P. and Beetham, W. P. (1992) Increased prevalence of migraine and chest pain in patients with primary Raynaud's disease. Ann. Int. Med. 116: 985-989.
301. Oliver, F. J., de la Rubia, G., Feener, E., Lee, M-E., Loeken, M. R., Shiba, T., Quertermous, T. and King, G. L. (1991) Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J. Biol. Chem. 266: 23251-23256.
302. Omland, T., Lie, R. T., Aakvaag, A., Aarsland, T. and Dickstein, K. (1994) Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89: 1573-1579.
303. Opgaard, O. S., Adner, M., Gulbenkian, S. and Edvinsson, L. (1994) Localization of endothelin unmunoreactivity and demonstration of constrictory endothelin A receptors in human coronary arteries and veins. J. Cardiovasc. Pharmacol. 23: 576-583.
304. Opgenorth, T., Wu Wong, J. R. and Shiosaki, K. (1992) Endothelin-converting enzymes. FASEB J. 6: 2653-2659.
305. B receptor subtype across the menstrual cycle. J. Clin. Endocrinol. Metab. 75: 1545-1549.
306. O'Reilly, G., Charnock-Jones, D. S., Morrison, J. J., Cameron, I. T., Davenport, A. P. and Smith, S. K. (1993) Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution. Biochem. Biophys. Res. Commun. 193: 834-840.
307. Ouchi, Y., Kim, S., Souza, A. C., Iijima, S., Hattori, A., Orimo, H., Yoshizumi, M., Kurihara, H. and Yazaki, Y. (1989) Central effect of endothelin on blood pressure in conscious rats. Am. J. Physiol. 256: H1747-H1751.
308. Pacher, R., Bergler-Klein, J., Globits, S., Teufelsbauer, H., Schuffer, M., Krauter, A., Ogris, E., Rodler, S., Nutte, M. and Hartter, E. (1993) Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. Am. J. Cardiol. 71: 1293-1299.
309. Palmer, R., Ferrige, A. and Moncada, S. (1987) Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
310. Patrignani, P., Del-Maschio, A., Bazzoni, G. and Daffonchi, L. (1992) Inactivation of endothelin by polymorphonuclear leukocyte-derived lytic enzymes. Blood 78: 2715-2720.
311. Perez-Vicario, F., Cooper, A., Corder, R., Fournier, A. and Warner, T. (1995) Rapid degradation of endothelin-1 by an enzyme released by the rat isolated perfused mesentery. Br. J. Pharmacol. 114: 867-871.
312. Perico, N., Cornejo, R. P., Benigni, A., Malachini, B., Ladny, J. R. and Remuzzi, G. (1991) Endothelin induces diuresis and natriuresis in the rat by acting on proximal tubular cells through a mechanism mediated by lipoxygenase products. J. Am. Soc. Nephrol. 2: 57-69.
313. Pernow, J., Franco-Cereceda, A., Matran, R. and Lundberg, J. M. (1989) Effect of endothelin-1 on regional vascular resistances in the pig. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S205-S206.
314. Plumpton, C., Champeny, R., Ashby, M., Kuc, R. E. and Davenport, A. P. (1993) Characterization of endothelin isoforms in human heart: endothelin-2 demonstrated. J. Cardiovasc. Pharmacol. 22: S26-S28.
315. Plumpton, C., Haynes, W. G., Webb, D. J. and Davenport, A. P. (1995) Measurement of C-terminal fragment of big-endothelin-1: a novel method for assessing the generation of endothelin-1 in humans. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S34-S36.
316. Pollock, D. M. and Opgenorth, T. J. (1991) Evidence for metalloprotease involvement in the in vivo effects of big endothelin-1. Am. J. Physiol. 261: R257-R263.
317. A receptor activation. Am. J. Physiol. 264: R222-R226.
318. Pollock, D. M., Divish, B. J., Milicic, I., Novosad, E. I., Burres, N. S. and Opgenorth, T. J. (1993) In vivo characterization of a phosphoramidon-sensitive endothelin-converting enzyme in the rat. Eur. J. Pharmacol. 231: 459-464.
319. 2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J. Biol. Chem. 269: 11938-11944.
320. Prinzmetal, M., Kennamer, R. and Merliss, R. (1959) A variant form of angina pectoris. Am. J. Med. 27: 375-388.
321. Properzi, G., Terenghi, G., Gu, X-H., Poccia, G., Pasqua, R., Francavilla, S. and Polak, J. M. (1995) Early increase precedes a depletion of endothelin-1 but not of Von Willebrands factor in cutaneous microvessels of diabetic patients: a quantitative immunohistochemical study. J. Pathol. 175: 243-252.
322. Rabelink, T. J., Kaasjager, K. A. H., Boer, P., Stroess, E. G., Braam, B. and Koomans, H. A. (1994) Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Kidney Int. 46: 376-381.
323. Rakugi, H., Nakamaru, M., Saito, H., Higaki, J. and Ogihara, T. (1988) Endothelin inhibits renin release from isolated rat glomeruli. Biochem. Biophys. Res. Commun. 155: 1244-1247.
324. Rakugi, H., Tabuchi, Y., Nakamaru, M., Nagano, M., Higashimoroi, K., Mikami, H., Ogihara, T. and Suzuki, N. (1990) Endothelin activates the vascular renin-angiotensin system in rat mesenteric arteries. Biochem. Int. 21: 867-872.
325. Raschak, M., Unger, L., Riechers, H. and Klinge, D. (1995) Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death (1995). J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S397-S399.
326. Ray, S. G., McMurray, J. J., Morton, J. J. and Dargie, H. J. (1992) Circulating endothelin is not extracted by the pulmonary circulation in man. Chest 102: 1143-1144.
327. Resink, T., Hahn, A. W., Scott-Burden, T., Powell, J., Weber, E. and Buhler, F. R. (1990) Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 168: 1308-1310.
328. Roberts-Thompson, P., McRitchie, R. J. and Chalmers, J. P. (1994) Experimental hypertension produces diverse changes in the regional vascular responses to endothelin-1 in the rabbit and the rat. J. Hypertens. 12: 1225-1234.
329. Rogerson, M. E., Cairns, H. S., Fairbanks, L. D., Westwick, J. and Neild, G. H. (1993) Endothelin-1 in the rabbit: interactions with cyclooxygenasc and NO-synthase products. Br. J. Pharmacol. 108: 838-843.
330. Roubert, P., Gillard, V., Plas, P., Guillon, J-M., Chabrier, P-E. and Braquet, P. (1989) Angiotensin II and phorbol-esters potently down-regulate endothelin (ET-1) binding sites in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 164: 809-815.
331. Roubert, P., Gillard, V., Plas, P., Chabrier, P. E. and Braquet, P. (1991) Binding characteristics of endothelin isoforms (ET-1, ET-2 and ET-3) in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 17 (Suppl. 5): S104-S108.
332. Roubert, P., Gillard-Roubert, V., Pourmarin, L., Cornet, S., Guilmard, C., Plas, P., Pirotzky, E., Chabrier, P. E. and Braquet, P. (1994) Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure. Mol. Pharmacol. 45: 182-188.
333. Roux, S., Loffler, B-M., Gray, G. A., Sprecher, U., Clozel, M. and Clozel, J. P., (1995) The role ot endothelin in experimental cerebral vasospasm Neurosurgery 37: 78-86.
334. B agonistic activity. Biochem. Biophys. Res. Commun. 179: 286-292.
335. Saito, Y., Nakao, K., Mukoyama, M. and Imura, H. (1990) Increased plasma endothelin level in patients with essential hypertension. N. Engl. J. Med. 322: 205.
336. B cndothelin receptor. Biochem. Biophys. Res. Commun. 178: 656-663.
337. Sakamoto, A., Yanagisawa, M., Sawamura, T., Enoki, T., Ohtani, T., Sakurai, T., Nakao, K., Toyo-oka, T. and Masaki, T. (1993) Distinct subdomains of human endothelin receptors determine their selectivity to endothelin A-selective antagonist and endothelin B-selective agonists. J. Biol. Chem. 268: 8547-8553.
338. Sakurai, T., Yanagisawa, M., Takuwa, Y., Miyazaki, H., Kimura, S., Goto, K. and Masaki, T. (1990) Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature 348: 732-735.
339. B receptor mRNA is down-regulated by endothelins through decreasing the intracellular stability of mRNA molecules. Biochem. Biophys. Res. Commun. 186: 342-347.
340. Samson, W. K., Skala, K. D., Alexander, B. D. and Huang, F. (1991) Hypothalamic endothelin: presence and effects related to fluid and electrolyte homeostasis. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S346-S349.
341. Sawamura, T., Kimura, S., Shinmi, O., Sugita, Y., Yanagisawa, M., Goto, K. and Masaki, T. (1990) Purification and characterization of putative endothelin-converting enzyme in bovine adrenal medulla: evidence for a cathepsin D like enzyme. Biochem. Biophys. Res. Commun. 168: 1230-1236.
342. Sawamura, T., Kasuya, Y., Matsushita, Y., Suzuki, N., Shinmi, O., Kishi, N., Sugita, Y., Yanagisawa, M., Goto, K., Masaki, T. and Kimura, S. (1991) Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells. Biochem. Biophys. Res. Commun. 174: 779-784.
343. Schiffrin, E. L. and Thibault, G. (1991) Plasma endothelin in human essential hypertension. Am. J. Hypertens. 4: 303-308.
344. Schiffrin, E. L., Deng, L. Y. and Larochelle, P. (1992) Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J. Hypertens. 10: 437-444.
345. Schini, V. B., Hendrickson, H., Heublein, D. M., Burnett, J. C. and Vanhoutte, P. M. (1989) Thrombin enhances the release of endothelin from cultured porcine aortic cells. Eur. J. Pharmacol. 165: 333-334.
346. Schmidt, M., Kroger, B., Jacob, E., Seulberger, H., Subkowski, T., Otter, R., Meyer, T., Schmalzing, G. and Hillen, H. (1994) Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett. 356: 238-243.
347. Schomisch-Moravec, C., Reynolds, E. E., Stewart, R. W. and Bond, M. (1989) Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem. Biophys. Res. Commun. 159: 14-18.
348. Seidah, N. G., Day, R., Marcinikiewicz, M. and Chretien, M. (1993) Mammalian paired basic amino acid convertases of prohormones and proproteins. Ann. NY Acad. Sci. 680: 135-146.
349. Seifert, V., Loffler, B. M., Zimmermann, M., Roux, S. and Stolke, D. (1995) Endothelin concentrations in patients with aneurysmal subarachnoid haemorrhage. J. Neurosurg. 82: 55-62.
350. B receptors in vascular endothelium and smooth muscle. Biochem. Biophys. Res. Commun. 191: 459-464.
351. Shichiri, M., Hirata, Y., Ando, K., Emori, T., Ohta, K., Kimoto, S., Ogura, M, Inoue, A. and Marumo, F. (1990) Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 15: 493-496.
352. Shimada, K., Takahashi, M. and Tanzawa, K. (1994) Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J. Biol. Chem. 269: 18275-18278.
353. Shimada, K., Matsushita, Y., Wakabayashi, K., Takahashi, M., Matsubara, A., Iijima, Y. and Tanzawa, K. (1995) Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem. Biophys. Res. Commun. 207: 807-812.
354. Shyamala, V., Moulthrop, T. H. M., Stratton-Thomas, J. and Tekamp-Olson, P. (1994) Two distinct human endothelin B receptors generated by alternative splicing from a single gene. Cell. Mol. Biol. Res. 40: 285-296.
355. Sokolovsky, M. (1992) Structure-function relationships of endothelins, sarafotoxins, and their receptor subtypes. J. Neurochem. 59: 809-821.
356. Sokolovsky, M. (1994) Endothelins and sarafotoxins: receptor heterogeneity. Int. J. Biochem. 26: 335-340.
357. Sokolowsky, M., Galron, R., Kloog, Y., Bdolah, A., Indig, F. E., Blumbers, S. and Fleminger, G. (1990) Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc. Natl. Acad. Sci. USA 87: 4702-4706.
358. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 325: 293-302.
359. Sørensen, S. S., Madsen, J. K. and Pedersen, E. B. (1994) Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am. J. Physiol. 266: F411-F418.
360. Spinella, M. J., Malik, A. B., Everitt, J. and Anderson, T. T. (1991) Design and synthesis of a specific endothelin 1 antagonist: effects on pulmonary vasoconstriction. Proc. Natl. Acad. Sci. USA 88: 7443-7446.
361. 125]endothelin binding sites in the region of the carotid bifurcation and brainstem of the cat: possible baro-and chemoreceptor involvement. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S385-S389.
362. Stanimirovic, D. B., McCarron, R. M. and Spatz, M. (1994) Dexamethasone down-regulates endothelin receptors in human cerebromicrovascular endothelial cells. Neuropeptides 26: 145-152.
363. Stasch, J-P., Hirth-Dietrich, C., Kazda, S., Kasda, S. and Neuser, D. (1989) Endothelin stimulates release of atrial natriuretic peptides in vitro and in vivo. Life Sci. 45: 869-875.
364. A antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide. J. Med. Chem. 37: 329-331.
365. Steiner, D. F., Smeekens, S. P., Ohagi, S. and Chan, S. J. (1992) The new enzymology of precursor processing endoproteases. J. Biol. Chem. 267: 23435-23438.
366. A receptor genes in essential hypertension. J. Cardiovasc. Pharmacol. 26: S9-S12.
367. Stewart, D. J. (1993) Endothelin in cardiopulmonary disease: factor paracrine vs neurohumoral. Eur. Heart J. 14 (Suppl. 4): 48-54.
368. Stewart, D. J., Levy, R. D., Cernacek, P. and Langleben, D. (1991) Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of hypertension? Ann. Intern. Med. 114: 464-469.
369. Strachan, F. E., Haynes, W. G. and Webb, D. J. (1995) Endothelium-dependent modulation of venoconstriction to sarafotoxin S6c in human hand veins in vivo. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S180-S182.
370. B receptors mediating venous smooth muscle contraction. Biochem. Biophys. Res. Commun. 200: 627-633.
371. B receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol. 107: 858-860.
372. Suzuki, H., Masaoka, R. H., Hirata, Y., Marumo, F., Isotani, E. and Hirakawa, K. (1992) The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid haemorrhage. J. Neurosurg. 77: 96-100.
373. Suzuki, N., Miyauchi, T., Tomobe, Y., Matsumoto, H., Goto, K., Masaki, T. and Fujino, M. (1990) Plasma concentrations of endothelin in spontaneously hypertensive and DOCA-salt hypertensive rats. Biochem. Biophys. Res. Commun. 167: 941-947.
374. Tahara, A., Kohno, M., Yanagi, S., Itagane, H., Toda, I., Akioka, I., Teragaki, M., Yasuda, M., Takeeuchi, K. and Takeda, T. (1991) Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty. Metabolism 40: 1235-1237.
375. Takada, J., Okada, K., Ikenaga, T., Matsumaya, K. and Yano, M. (1991) Phosphoramidon-sensitive endothelin-converting enzyme in the cytosol of cultured bovine endothelial cells. Biochem. Biophys. Res. Commun. 176: 860-865.
376. Takahashi, M., Matsushita, Y., Iijima, Y. and Tamawa, K. (1993) Purification and characterization of endothelin-converting enzyme from rat lung. J. Biol. Chem. 268: 21394-21398.
377. B receptor. Biochem. Biophys. Res. Commun. 184: 953-959.
378. Takaoka, M., Takenobu, Y., Miyata, Y., Ikegawa, R., Matsumura, Y. and Morimoto, S. (1990a) Mode of cleavage of pig big endothelin-1 by chymotrypsin. Biochem. J. 270: 541-544.
379. Takaoka, M., Takenobu, Y., Miyata, Y., Ikegawa, R., Matsumura, Y. and Morimoto, S. (1990b) Pepsin, an aspartic protease, converts porcine big endothelin to 21-residue endothelin. Biochem. Biophys. Res. Commun, 166: 436-442.
380. Takase, H., Moreau, P. and Lüscher, T. F. (1995) Endothelin receptor subtypes in small arteries: studies with FR139317 and bosentan. Hypertension 25: 739-743.
381. Takeda, Y., Itoh, Y., Yoneda, T., Miyamori, I. and Takeda, R. (1993) Cyclosporin A induces endothelin-1 release from cultured rat vascular smooth muscle cells. Eur. J. Pharmacol. 233: 2-3.
382. Tanaka, T., Tsukuda, E., Nozawa, M., Nonoka, H., Ohno, T., Kase, H., Yamada, K. and Matsuda, Y. (1994) RES-701-1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin. Mol. Pharmacol. 45: 724-730.
383. B receptors in canine coronary arteries. Circulation 74: 105-114.
384. Teerlink, J. R., Löffler, B-M., Hess, P., Clozel, M. and Clozel, J. P. (1994b) Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure: acute effects of the endothelin receptor antagonist Ro 47-0203 (Bosentan). Circulation 90: 2510-2518.
385. Tohmo, H., Karanko, M., Korpilahti, K., Scheinin, M., Vinamaki, O. and Nenvonen, P. (1994) Enalapnlat in acute intractable heart failure after myocardial infarction: a prospective, consecutive sample, before-after trial. Crit. Care Med. 22: 965-973.
386. Tokunaga, O., Fan, J., Watanabe, T., Kobayashi, M., Kumazaki, T. and Mitsui, Y. (1992) Endothelin: immunohistologic localization in aorta and biosynthesis by cultured human aortic endothelial cells. Lab. Invest. 67: 210-217.
387. Tomobe, Y., Miyauchi, T., Saito, A., Yanagisawa, M., Kimura, S., Goto, K. and Masaki, T. (1988) Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto rats. Eur. J. Pharmacol. 152: 373-374.
388. Tonnessen, T., Naess, P. A., Kirkeboen, K. A., Ilebekk, A. and Christensen, G. (1993) Alterations in plasma endothelin during passage through the left heart chambers before and after brief myocardial ischaemia. Cardiovasc. Res. 27: 2160-2163.
389. Touyz, R. M., Tolloczko, B. and Schiffrin, E. L. (1994) Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium reponses to angiotensin II but not to endothelin-1. J. Hypertens. 12: 663-673.
390. Trapani, A. J., De Lombaert, S., Kuzmich, S. and Jeng, A. Y. (1995) Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S69-S71.
391. Tschudi, M. R. and Lüscher, T. F. (1994) Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor. Biochem. Biophys. Res. Commun. 204: 685-690.
392. B receptor antagonist blocks proliferation of rat vascular smooth muscle cells after balloon angioplasty. Life Sci. 56: L449-PL454.
393. Tsurumi, Y., Ohhata, N., Iwamoto, T., Shigematsu, N., Sakamoto, K., Nishikawa, M., Kiyoto, S. and Okuhara, M. (1994) WS79089A, B and C, new endothelin converting enzyme inhibitors isolated from Streptosporangium roseum. No. 79089. J. Antibiot. 47: 619-631.
394. Tsurumi, Y., Ueda, H., Hayashi, K., Takase, S., Nishikawa, M., Kiyoto, S. and Okuhara, M. (1995) WS75624 A and B, new endothelin converting enzyme inhibitors isolated from Saccharothrix sp. No. 75624. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. J. Antibiot. 48: 1066-1072.
395. Turner, A. J. and Murphy, L. J. (1995) Molecular pharmacology of endothelin converting enzymes. Biochem. Pharmacol. 51: 91-102.
396. Valdenaire, O., Rohrbacher, E. and Mattei, M. G. (1995) Organisation of the gene encoding the human endothelin-converting enzyme. J. Biol. Chem. 270: 29794-29798.
397. Valentin, J. P., Gardner, D. G., Wiedemann, E. and Humpherics, M. H. (1991) Modulation of endothelin effects on blood pressure and hematocrit by atrial natriuretic peptide. Hypertension 17: 864-869.
398. Valesco, C. E., Turner, M., Inagami, T., Atkinson, J. B., Virmani, R., Jackson, E. K., Murray, J. J. and Forman, M. B. (1994) Reperfusion enhances the local release of endothelin after regional myocardial ischaemia. Am. Heart J. 128: 421-451.
399. Vallance, P. and Moncada, S. (1994) Nitric oxide-from mediator to medicines. J. R. Coll. Physicians Lond. 28: 209-219.
400. Vallance, P., Collier, J. and Moncada, S. (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii: 997-1000.
401. Vane, J. R., Anggard, E. A. and Botting, R. M. (1990) Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323: 27-36.
402. Vemulapalli, S., Chui, P. J. S., Rivelli, M., Foster, C. J. and Sybertz, E. J. (1991) Modulation of circulating endothelin levels in hypertension and endotoxaemia in rats. J. Cardiovasc. Pharmacol. 18: 895-903.
403. Véniant, M., Clozel, J. P., Hess, P. and Clozel, J. P. (1994) Endothelin plays a role in the maintenance of blood pressure in normotensive guinea pigs. Life Sci. 55: 445-454.
404. Vierhapper, H. O., Wagner, P., Nowotny, P. and Walhausl, W. (1990) Effect of endothelin in man. Circulation 81: 1415-1418.
405. Vierhapper, H., Wagner, O. F., Nowotny, P. and Waldhausl, W. (1992) Effect of endothelin-1 in man: pretreatment with nifedipine, with indomethacin and with cyclosporine A. Eur. J. Clin. Invest. 22: 55-59.
406. Vijayaraghaven, J., Scili, A. G., Carretero, O. A., Slaughter, C., Moomaw, C. and Hersh, L. B. (1990) The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J. Biol. Chem. 265: 14150-14155.
407. Wagner, O. F., Christ, G. and Wojta, T. (1992a) Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem. 267: 16066-16068.
408. Wagner, O. F., Vierhapper, H., Gasic, S., Nowotny, P. and Waldhausl, W. (1992b) Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation. Eur. J. Clin. Invest. 22: 277-282.
409. Wake, R. P. and Pang, C. C. Y. (1992) The sympathetic nervous system facilitates endothelin-1 effects on venous tone. J. Pharmacol. Exp. Ther. 260: 45-50.
410. Wang, D. L., Tang, C. C., Wung, B. S., Chen, H. H., Hung, M. S. and Wang, J. J. (1993) Cyclical strain increases endothelin-1 secretion and gene expression in human endothelial cells. Biochem. Biophys. Res. Commun. 195: 1050-1056.
411. B receptor mRNAs after balloon angioplasty in the rat. J. Cardiovasc. Pharmacol. 26 (Suppl. 3): S22-S25.
412. Warner, T. D. (1994) Endothelin receptor antagonists. Cardiovasc. Drug Rev. 12: 105-122.
413. Warner, T. D., De Nucci, G. and Vane, J. R. (1989) Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur. J. Pharmacol. 159: 325-326.
414. Warner, T. D., Allcock, G. H., Corder, R. and Vane, J. R. (1993) Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br. J. Pharmacol. 110: 777-782.
415. Warner, T. D., Allcock, G. H. and Vane, J. R. (1994) Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065. Br. J. Pharmacol. 112: 207-213.
416. Watanabe, Y., Naruse, M., Monzen, C., Naruse, K., Ohsumi, K., Horiuchi, J., Yoshihara, I., Kato, Y., Nakamura, N., Kato, H., Sugino, N. and Demura, H. (1991a) Is big endothelin converted to endothelin-1 in circulating blood? J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S503-S505.
417. Watanabe, T., Suzuki, N., Shimamoto, N., Fujino, M. and Imada, A. (1991b) Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ. Res. 69: 370-377.
418. B receptor antagonist in rats. Br. J. Pharmacol. 114: 949-954.
419. Wei, C. M., Lerman, A., Rodeheffer, R. J., McGregor, C. G. A., Brandt, R. R., Wright, S., Heublein, D. M., Kao, K., Edwards, W. D. and Burnett, J. C. (1994) Endothelin in human congestive heart failure. Circulation 89: 1580-1586.
420. Weiser, E., Wollberg, Z., Kochva, E. and Lee, Y. (1984) Cardiotoxic effects of the venom of the burrowing asp, Actractaspis engaddensis (Actractaspididae, Ophidia). Toxicon 22: 767-774.
421. Weitzberg, E., Ahlborg, G. and Lundherg, J. M. (1991) Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues. Biochem. Biophys. Res. Commun. 180: 1298-1303.
422. Wenzel, R. R., Noll, G. and Luscher, T. F. (1994) Endothelin receptor antagonists inhibit endothelin in human skin microcirculation. Hypertension 23: 581-586.
423. Whittle, B. J. R., Lopez-Belmonte, J. and Rees, D. D. (1989) Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br. J. Pharmacol. 98: 646-652.
424. Wieczorek, I., Haynes, W. G., Webb, D. J., Ludlam, C. A. and Fox, K. A. A. (1994) Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome. Br. Heart J. 72: 436-441.
425. Willette, R. N., Ohlstein, E. H., Pullen, M., Sauermelch, C. F., Cohen, A. and Nambi, P. (1993) Transient forebrain ischaemia alters acutely endothelin receptor density and immunoreactivity in gerbil brain. Life Sci. 52: 35-40.
426. Williams, D. L., Jones, K. L., Pettibone, D. J., Lis, E. V. and Clineschmidt, B. V. (1991) Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res. Commun. 175: 556-561.
427. Wilson, D., Dorfman, D. and Orkin, S. (1990) A non-erythroid GATA-binding protein is required for function of the human preproendothelin-1 promoter in endothelial cells. Mol. Cell. Biol. 10: 4854-4862.
428. Winkles, J. A., Alberts, G. F., Brogi, E. and Libby, P. (1993) Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem. Biophys. Res. Commun. 191: 1081-1008.
429. Wollberg, Z., Shabo-Shina, R., Intrator, N., Bdolah, A., Kochra, E., Shavit, G., Oran, Y., Vidne, B. A. and Gitter, S. (1987) A novel cardiotoxic polypeptide from the venom of Actractapis engaddensis (burrowing asp): cardiac effects in mice and isolated rat and human heart preparations. Toxicon 26: 525-534.
430. Wong, J., Vanderford, P. A., Fineman, J. R., Chang, R. and Soifer, S. J. (1993) Endothelin-1 produces pulmonary vasodilation in the intact newborn lamb. Am. J. Physiol. 265: H1318-H1325.
431. Wong-Dusting, H. K., La, M. and Rand, M. J. (1990) Mechanisms of the effects of endothelin on responses to noradrenaline and sympathetic nerve stimulation. Clin. Exp. Pharmacol. Physiol. 17: 269-273.
432. Wypij, D. M., Nichols, J. S., Novak, P. J., Stacy, D. L., Bermart, J. and Wiseman, J. S. (1992) Role of mast cell chymase in th extracellular processing of big endothelin-1 to endothelin-1 in the perfused rat lung. Biochem. Pharmacol. 43: 845-853.
433. Xu, D., Emoto, N., Giaid, A., Slaughter, C., Kaw, S., deWit, D. and Yanagisawa, M. (1994) ECE-1: a membrane bound metalloprotease that catalyzes the proteolyic activation of big endothelin-1. Cell 78: 473-485.
434. Yamamoto, T., Kimura, T., Ota, K., Shoji, M., Inoue, M., Sato, K., Ohta, M. and Yoshinaga, K. (1991) Central effects of endothelin-1 on vasopressin and atrial natriuretic peptide release and cardiovascular and renal function in conscious rats. J. Cardiovasc. Pharmacol. 17 (Suppl. 7): S316-S318.
435. Yamamura, I., Tam, E., Maeda, Y., Minami, N. and Shindo, H. (1992) Endothelin-1 of canine basilar artery in vasospasm. J. Neurosurg. 76: 99-105.
436. Yan, L. S., Hui, C. and Van, G. Q. (1990) Role of endothelin in the pathogenesis of hypertension in spontaneously hypertensive rats and 2 kidneys 1 clip rats. Chin. Med. J. 103: 748-753.
437. Yanagisawa, M., Inoue, A., Ishikawa, T., Kasuwa, Y., Kimura, S., Kumagaye, S. I., Nakajima, K., Watanabe, T., Sakakibra, S., Goto, K. and Masaki, T. (1988a) Primary structure, synthesis and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc. Natl. Acad. Sci. USA 85: 6964-6968.
438. Yanagisawa, M., Kurihara, H., Kimuni, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. and Masaki, T. (1988b) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
439. A gene. Biochem. Biophys. Res. Commun. 190: 332-339.
440. Yang, X., Madeddu, P., Micheletti, R., English, E., Rossi, R., Giacatone, G., Benatti, P. and Bianchi, G. (1991) Effects of intravenous endothelin on hemodynamics and cardiac contractility in conscious Milan normotensive rats. J. Cardiovasc. Pharmacol. 17: 662-669.
441. Yang, Z. H., Richard, V., von Segesser, L., Bauer, E., Stulz, P., Turina, M. and Luscher, T. F. (1990) Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm? Circulation 82: 188-195.
442. Yokokawa, K., Tahara, H., Kohno, M., Murakawa, K., Yasunari, K., Nakagawa, K., Hamada, T., Otani, S., Yanagisawa, M. and Takeda, T. (1991) Hypertension associated with endothelin-secreting malignant haemangioendothelioma. Ann. Intern. Med. 114: 213-215.
443. Yokokawa, K., Tahara, H., Kohno, M., Mandal, A. K., Yanagisawa, M. and Takeda, T. (1993) Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. J. Clin. Invest. 92: 2080-2085.
444. B-receptor mRNA in the lung of rats with pulmonary hypertension. J. Cardiovasc. Pharmacol. 22 (Suppl. 8): S336-S338.
445. Yorimitsu, K., Moroi, K., Inagaki, N., Saito, T., Masuda, Y., Masaki, T., Seino, S. and Kimura, S. (1995) Cloning and sequencing of a human endothelin converting enzyme in renal adenocarcinoma (ACHN) cells producing endothelin-2. Biochem. Biophys. Res. Commun. 208: 721-727.
446. Yu, J. C. M. and Davenport, A. P. (1995) Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br. J. Pharmacol. 114: 551-557.
447. Zamora, M. R., O'Brien, R., Rutherford, R. B. and Weil, J. V. (1990) Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet 336: 1144-1147.
448. Zeiher, A. M., Goebel, H., Schachinger, V. and Ihling, C. (1995) Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: a clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 91: 941-947.
449. Zelis, R. and Flaim, S. F. (1982) Alterations in vasomotor tone in congestive heart failure. Prog. Cardiovasc. Dis. 24: 437-459.
450. Zerkowski, H-R., Broede, A., Kunde, K., Hillemen, S., Scafer, E., Vogelsang, M., Michel, M. C. and Brodde, O-E. (1992) Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn Schmeidebergs Arch. Pharmacol. 347: 347-352.
451. Zhao, X., Fu, W. J., Yuan, W. J., Hou, G. X., Chen, J. G., Xia, J. H. and Zhu, H. N. (1994) Influence of endothelin-1 on ventricular fibrillation threshold in acute myocardial ischaemic rats. Acta Pharmacol. Sin. 15: 363-366.
452. Zhu, G., Wu, L. H., Mauzy, C., Egloff, A. M., Mirzadegan, T. and Chung, F. Z. (1992) Replacement of lysine-181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling. J. Cell. Biochem. 50: 159-164.
453. Ziv, I., Fleminger, G., Djaldetti, R., Achiron, A., Melamed, E. and Sokolovsky, M. (1992) Increased plasma endothelin-1 in acute ischaemic stroke. Stroke 23: 1014-1016.